ABOUT this BLOG and How to use it

WELCOME to Stu's Views and MS News e-Newsletter Ô

Key-Note: Our live MS educational seminars average approx 65 people per educational program and SINCE our first program in February 2010, we have hosted more than 118 educational programs. Most locations are in Florida and we have now added educational events in Georgia, Alabama and the Carolinas.

Register at our website to receive our globally transmitted Multiple Sclerosis e-newsletter, currently being received in more than (90) Countries.

Visit MS Views and News.org

Be Empowered with MS News and Information

Scroll to view All the resources found on the left side of this blog. Need to find information, use our 'search by topic' tool.


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Monday, January 28, 2013

Sanofi Moves Closer to Multiple Sclerosis Drug Approval


Sanofi (NYSE: SNY  announced today that the Food and Drug Administration accepted its supplemental Biologics License Application requesting permission to market Lemtrada for the treatment of relapsing multiple sclerosis.
The active ingredient in Lemtrada was originally approved as Campath to treat leukemia, but Sanofi pulled Campath off the market, with some speculating that this was because the difference between the leukemia dose and the multiple sclerosis dose would have made the drug extremely cheap for the multiple sclerosis patients.
The marketing application is based on two phase 3 studies comparing Lemtrada to Pfizer(NYSE: PFE  ) and Merck KGaA's Rebif. One study compared the drugs in patients new to treatment while the other tested patients who had relapsed while on a prior therapy.
Sanofi expects a decision from the FDA in the second half of the year. A decision from the Committee for Medicinal Products for Human Use in the EU is expected in the second quarter

read more
..


If you would like, you can comment to our blog posts
 LIKE this Blog by clicking the LIKE button - top left
 REMAIN up to date with MS News and Education
Visit: www.msviewsandnews.org  to register
.

1 comment:

wayne fenton said...

heaven forbid you sell something to a ms patient that they can actually afford , and what are the side effects are they as bad as the disease itself.